InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Murray Dallan. Insider active across 1 company, notably Sarepta Therapeutics, Inc.. Cumulatively, 6 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €474k. History available since 2 May 2024. The latest transaction was filed on 4 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Murray Dallan is a declarant linked to Sarepta Therapeutics, Inc. (XNAS), where the listed role is Chief Customer Officer. Across 6 filings in total, the 6 sampled filings cover the period from 2024-05-06 to 2025-03-11, with EUR 0 of buys and EUR 474142 of sells; the modal transaction nature is Levée d'options.